Physician profile
Kimberly E Smith
NPI 1518072693
$2,583.27
in general payments reported to CMS, 2019-2025
20 companies · $22.24 in 2025
The $22.24 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $201 · 2021: $16.33 · 2022: $16.04 · 2024: $39.63 · 2025: $22.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb Biosciences INC. | $1,718.26 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $154.34 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $99.00 | 2020 | |
| Lilly USA, LLC | $97.82 | 2019 | |
| Genentech USA, INC. | $82.93 | 2019 | |
| Galderma Laboratories, L.P. | $79.34 | 2019 | |
| Celgene Corporation | $65.10 | 2019 | |
| Vyne Pharmaceuticals INC. | $49.79 | 2020-2021 | |
| Regeneron Pharmaceuticals, INC. | $45.00 | 2019 | |
| Glaxosmithkline, LLC. | $36.71 | 2019-2020 | |
| Allergan, INC. | $24.91 | 2019 | |
| Sandoz INC. | $23.23 | 2024 | Hyrimoz |
| Vanda Pharmaceuticals INC. | $22.40 | 2020 | |
| Cipher Pharmaceuticals US LLC | $22.24 | 2025 | Spinosad, Natroba |
| Abbvie INC. | $16.40 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.38 | 2020 | |
| Journey Medical Corporation | $16.04 | 2022 | |
| Almirall LLC | $13.38 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly E Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.